Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
